Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive degeneration of the upper and lower motor neurons,
1 with approximately half of the patients dying within 3 years of onset.
2 The ALS incidence rate is between 1.5 and 2.5 per 100 000 persons per year
3 and increases with increasing age, although incidence appears to decrease after age 80 years.
4 Although a recent study found ALS heritability to be higher than previously reported,
5 the etiology of ALS pathogenesis is not completely understood, with environmental contributions likely contributing to the disease.
2 Because of the rarity of the disease, large-scale cohort studies are difficult and so have not commonly been used to investigate potential risk factors, but the need for more such studies has been recognized.
6